Genome Web Breaking News
- Admera Health Seeks to Divest Pharmacogenomics, Clinical Services Business
- MD Anderson, BostonGene Ink Collaboration to Develop Cancer Diagnostics
- Public-Private Data Science Collaboration to ID Alzheimer's, Other Neurodegenerative Risk Factors
- Schott Minifab Acquires Applied Microarrays to Expand US Manufacturing Capabilities
- Genetic Technologies, WashU Team up to Study Breast Cancer Risk in Woman of African Descent
Stat
- Behind Epic’s algorithm to detect sepsis before it progresses
- STAT+: Pharmalittle: Sanofi ends work on mRNA Covid-19 vaccine; Biogen seeks fast FDA approval of another Alzheimer’s drug
- STAT+: STAT+ Conversation: How medicine’s biggest journals are confronting racism
- STAT+: Graduate students launch an entrepreneurship program to bring new faces to biotech
- STAT+: Biogen, Eisai seek fast approval for second Alzheimer’s drug, relying on relaxed FDA standard
NYT science news
- This May Be the First Planet Found Orbiting 3 Stars at Once
- How Covid Misinformation Created a Run on Animal Medicine
- Transgender Youth Face Multiple Barriers to Health Care, Study Finds
- For Transgender Youth, Stigma Is Just One Barrier to Health Care
- This Fjord Shows Even Small Populations Create Giant Microfiber Pollution
Fierce Biotech
- Vensana Capital redoubles medtech investment efforts with $325M 2nd fund
- Ziopharm's new CEO cuts 50% of workforce amid trial delays for T-cell receptor therapy
- Shionogi licenses out 3rd-gen HIV asset to ViiV, notches a flop in chronic cough
- Here we go again: Eisai starts rolling FDA approval submission for Biogen-partnered Alzheimer's drug
- Valneva, hit by COVID contract chaos, sees Lyme disease vaccine drop-off in phase 2, but boosters helping
Fierce Medical Devices
- Vensana Capital redoubles medtech investment efforts with $325M 2nd fund
- Eyevensys links with Phillips-Medisize, Minnetronix to produce its gene therapy device for eye diseases
- With $135M in the bank, Elligo taps new buyout to build out its digital R&D platforms
- Zebra Medical earns its stripes with FDA nod for AI to catch calcium build-up in arteries
- Novo Nordisk to smarten up its disposable insulin pens with digital diabetes devicemaker Biocorp